Risperidone long-acting for alcohol and schizophrenia treatment (R-LAST)
Phase of Trial: Phase IV
Latest Information Update: 25 Mar 2018
At a glance
- Drugs Risperidone (Primary) ; Risperidone
- Indications Alcoholism; Schizoaffective disorder; Schizophrenia
- Focus Proof of concept; Therapeutic Use
- Acronyms R-LAST
- 02 Nov 2010 Actual end date (July 2010) added as reported by ClinicalTrials.gov.
- 02 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2009 Planned end date changed from 1 Jun 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.